Don’t employ a specific direct oral anticoagulant [DOAC] reversal agent without identifying the DOAC and estimating its plasma concentration. Posted November 3rd, 2022 by Nick Mackara & filed under .
Do not measure the INR in patients who are taking an anti-Xa inhibitor. Posted November 3rd, 2022 by Nick Mackara & filed under .
Don’t order ANA and ENA unless the patient is suspected to have a connective tissue disease. Posted November 3rd, 2022 by Nick Mackara & filed under .
Don’t perform an extensive work-up in otherwise healthy neutropenic patients of African or Middle Eastern ancestry prior to Duffy-null phenotype testing. Posted November 3rd, 2022 by Nick Mackara & filed under .
Don’t repeat HbA1c testing in stable patients within 3 months of a previous result. Posted November 3rd, 2022 by Nick Mackara & filed under .
Don’t order tissue transglutaminase IgG antibody or Deamidated Gliadin Peptide (DGP) antibodies (IgG or IgA) in the initial screening for Celiac Disease. Posted November 3rd, 2022 by Nick Mackara & filed under .
Do not prescribe immune suppressive agents for suspected autoimmune hepatitis (AIH) without first excluding hepatotropic virus infections (e.g., viral hepatitis A, B, and C). Viral hepatitis may mimic AIH, both serologically and histologically, features that may resolve with direct-acting antiviral (DAA) treatment. Posted November 3rd, 2022 by Nick Mackara & filed under .
Do not test for influenza unless the patient is symptomatic and the result will influence clinical management and decision making. Posted November 3rd, 2022 by Nick Mackara & filed under .
Do not routinely send urine for Chlamydia trachomatis and Neisseria gonorrhoeae (CT/NG) testing from females if vaginal swab collection is possible. Posted November 3rd, 2022 by Nick Mackara & filed under .
AANEM11-Don’t use neuromuscular ultrasound (NMUS) to evaluate the severity of carpal tunnel syndrome. Posted September 8th, 2022 by Nick Mackara & filed under .
ASCP10-Don’t use strong CYP3A4 and P-glycoprotein inhibitors or inducers with Direct Oral Anticoagulants (DOACs) and periodically assess the medication regimen for such drug-drug interactions. Posted June 8th, 2022 by Nick Mackara & filed under .
ASCP9-Don’t prescribe tramadol for older adults without due consideration of the potential risks and harms related to serotonergic excess, seizures, falls and drug-drug interactions. Posted June 8th, 2022 by Nick Mackara & filed under .
ASCP8-Don’t combine opioids with benzodiazepines or gabapentinoids to treat pain in older adults and re-evaluate routinely for deprescribing during chronic use. Posted June 8th, 2022 by Nick Mackara & filed under .
ASCP7-Don’t use three or more CNS-active medications (antidepressants, benzodiazepines, Z-drugs, opioids, gabapentinoids, antipsychotics, antiepileptics), especially in older adults. Posted June 8th, 2022 by Nick Mackara & filed under .
ASCP6-Don’t prescribe or routinely continue medications for older adults with limited life expectancy without due consideration to individual goals of care, presence of comorbidities and time-to-benefit for preventive medications. Posted June 8th, 2022 by Nick Mackara & filed under .
